Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary

• Takeda Pharmaceutical Company Limited 4502.T reported quarterly adjusted earnings of JPY116.95​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of JPY-7.48. The mean expectation of three analysts for the quarter was for earnings of JPY45.38 per share. Wall Street expected results to range from JPY45.30 to JPY45.45 per share.

• Revenue rose 6.7% to JPY1.19 trillion from a year ago; analysts expected JPY1.16 trillion.

• Takeda Pharmaceutical Company Limited's reported EPS for the quarter was JPY116.95​.

• The company reported quarterly net income of JPY192.43 billion.

• Takeda Pharmaceutical Company Limited shares had risen by 9.1% this quarter and gained 30.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 9.4% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Takeda Pharmaceutical Company Limited is JPY6,800.00, about 4.8% above its last closing price of JPY6,471.00

This summary was machine generated from LSEG data October 29 at 12:12 p.m. UTC. ​All figures in yen unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)